Switzerland

cellvie

2022 2022 Winner | Venture Winner Science Start-ups (Falling Walls Venture)

Born in the US and raised in Switzerland, cellvie is seeking to bring about a new treatment modality: Therapeutic Mitochondria Transplantation, which was conceived at Harvard Medical School. It involves the transfer of viable mitochondria into cells where the energy metabolism has been compromised or is in need of amplification.

cellvie is pursuing this technology as a platform, seeking to establish the mitochondria’s potential in ischemia-reperfusion injury, gene therapy and aging related degeneration. The first application will be in heart-attack patients, an indication where cellvie’s co-founder showed the potential for a 60%-reduction in muscle damage in a corresponding large animal study. If the team succeeds, their work may spur a whole new industry around mitochondria as a category of medicines.

Content by this speaker

Explore more content of Falling Walls

Further Activities to have a look at

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.